DAFNA Capital Management’s NextCure NXTC Stock Holding History

DAFNA Capital Management’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,849	Closed	-$214K	–	80
2023 Q3	$214K	Sell	13,849 -1,792	-11%	-$34.2K	0.07%	70
2023 Q2	$338K	Hold	15,641	–	–	0.09%	65
2023 Q1	$278K	Hold	15,641	–	–	0.08%	67
2022 Q4	$265K	Hold	15,641	–	–	0.07%	71
2022 Q3	$516K	Hold	15,641	–	–	0.14%	69
2022 Q2	$882K	Hold	15,641	–	–	0.24%	66
2022 Q1	$912K	Hold	15,641	–	–	0.24%	72
2021 Q4	$1.13M	Buy	15,641 +350	+2%	+$29.3K	0.28%	62
2021 Q3	$1.24M	Hold	15,291	–	–	0.33%	65
2021 Q2	$1.47M	Buy	15,291 +9,874	+182%	+$1.01M	0.31%	64
2021 Q1	$651K	Hold	5,417	–	–	0.15%	80
2020 Q4	$709K	Sell	5,417 -1,666	-24%	-$215K	0.21%	64
2020 Q3	$748K	Buy	7,083 +5,416	+325%	+$666K	0.24%	64
2020 Q2	$429K	Hold	1,667	–	–	0.12%	77
2020 Q1	$741K	Hold	1,667	–	–	0.31%	58
2019 Q4	$1.13M	Buy	+1,667	New	+$836K	0.39%	56
2019 Q3	–	Sell	-8,008	Closed	-$1.44M	–	91
2019 Q2	$1.44M	Buy	+8,008	New	+$1.66M	0.54%	50

Other funds holding NXTC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

DAFNA Capital Management's NXTC Position: Q4 2023 in Review

DAFNA Capital Management sold out of NextCure (NXTC) in Q4 2023, closing a stake of 13,849 shares — an estimated $214K sold.

DAFNA Capital Management first reported a position in NXTC in Q2 2019 and held it in 17 quarters. The position peaked at $1.47M in Q2 2021. 43 funds tracked by Wall St. Rank hold NXTC as of Q4 2023.

DAFNA Capital Management reported no remaining NextCure position as of Q4 2023 after selling out during the quarter.
DAFNA Capital Management sold 13,849 NextCure shares in Q4 2023, an estimated $214K.
DAFNA Capital Management first reported a position in NextCure in Q2 2019 and held it in 17 quarters.
DAFNA Capital Management's NextCure position peaked at $1.47M in Q2 2021.
43 funds tracked by Wall St. Rank held NextCure as of Q4 2023.

Based on DAFNA Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.